scholarly article | Q13442814 |
P356 | DOI | 10.1097/SHK.0000000000000497 |
P698 | PubMed publication ID | 26771933 |
P50 | author | Oriol Roca | Q41590866 |
Juan P. Barret | Q42881867 | ||
P2093 | author name string | Joan R Masclans | |
Mireia Ruiz-Castilla | |||
P433 | issue | 2 | |
P921 | main subject | biomarker | Q864574 |
P304 | page(s) | 117-125 | |
P577 | publication date | 2016-02-01 | |
P1433 | published in | Shock | Q7499831 |
P1476 | title | RECENT ADVANCES IN BIOMARKERS IN SEVERE BURNS. | |
P478 | volume | 45 |
Q52611408 | Checking procalcitonin suitability for prognosis and antimicrobial therapy monitoring in burn patients. |
Q40060254 | Differential regulation of innate immune cytokine production through pharmacological activation of Nuclear Factor-Erythroid-2-Related Factor 2 (NRF2) in burn patient immune cells and monocytes. |
Q58763790 | Procalcitonin kinetics after burn injury and burn surgery in septic and non-septic patients - a retrospective observational study |
Q55526241 | Résumés de la table ronde du 37ème Congrès De La SFB, 8 Juin 2017. |
Q39746527 | The clinical significance of the MIF homolog d-dopachrome tautomerase (MIF-2) and its circulating receptor (sCD74) in burn |
Q90049274 | Trends in microbial profile of burn patients following an event of dust explosion at a tertiary medical center |
Search more.